Imunoterapia: acesso aberto

Imunoterapia: acesso aberto
Acesso livre

ISSN: 2471-9552

Volume 3, Emitir 1 (2017)

Artigo de revisão

Overview of the Soluble and Membrane-bound Tumor Factors Limiting NK-mediated Immune Surveillance

Cristina Bottino, Mariella Della Chiesa, Alessandra Dondero*, Francesca Bellora, Beatrice Casu, Alessandro Moretta and Roberta Castriconi

Compartilhe este artigo

Artigo de Pesquisa

Aviscumine (ME-503)-Skin Reaction as significant Factor for its Efficacy Expanded Evaluation of the Results from the Phase II Trial NCT00658437 in Patients with Unresectable stage IV Metastatic Melanoma

Uwe Trefzer, Ralf Gutzmer, Tabea Wilhelm, Florian Schenck, Katharina C. Kähler, Volkmar Jacobi, Klaus Witthohn, Hans Lentzen* and Peter Mohr

Compartilhe este artigo

Artigo de revisão

The Excellent Antitumor Effect of IL-24 and the Complete Eradication of the Xenograft Tumor with CTGVT-DG Strategy

Xin-Yuan Liu*,Kang-Jian Zhang,Jin-Fa Gu, Xian-Long Fangi, Ai-min Ni,Sheng-Fei He and Qi Kang

Compartilhe este artigo
Top